8-KItem 5.02 · Officer/Director Change
Boston Scientific ($BSX) says director Yoshiaki Fujimori told the company on Feb 2, 2026 he will not stand…
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) says director Yoshiaki Fujimori told the company on Feb 2, 2026 he will not stand for re‑election at the 2026 Annual Meeting. He’s served on the Board since July 2016 and will remain in place until the meeting. 🗓️ #BoardChange #MedTech
Fujimori currently chairs BSX’s Risk, Science & Technology Committee. The Board and Nominating & Governance Committee will evaluate Board size/composition and potential additions. Company says his decision is not due to any disagreement. $BSX 🔎 #CorporateGovernance